PubRank

Rita Schmutzler

Author PubWeight™ 21.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010 1.90
2 AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev 2007 1.75
3 Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett 2008 1.54
4 Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010 1.41
5 Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 2009 1.37
6 A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res 2012 1.21
7 Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 2005 1.10
8 Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium. J Med Genet 2013 1.05
9 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
10 Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. Gynecol Oncol 2006 0.96
11 Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol Genet 2012 0.94
12 Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set. Int J Cancer 2007 0.90
13 COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res 2013 0.90
14 Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology 2010 0.88
15 2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol 2008 0.86
16 Activating somatic FGFR2 mutations in breast cancer. PLoS One 2013 0.86
17 Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. J Clin Oncol 2011 0.84
18 DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. Int J Cancer 2014 0.84
19 The CpG island methylator phenotype in breast cancer is associated with the lobular subtype. Epigenomics 2014 0.80
20 A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8. Oncogene 2005 0.77
21 The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2011 0.75
22 Benefits and risks of breast cancer screening. Oncol Res Treat 2014 0.75